Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rothen

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Archives of Public Health = Archives Belges De Sante Publique|May 29, 2023
Improving value for underserved populations with a community-based intervention: a retrospective cohort studyClaude Pinnock, John Rothen, Tom Carlough, et al.
JAMA Oncology|May 7, 2026
Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate CancerMichael S Leapman, John Rothen, Jessica B Long, et al.
JAMA Network Open|May 27, 2026
Medicare Insurance Type and Broad Genomic Profiling in Metastatic CancerRyan D Chow, John Rothen, Jessica B Long, et al.
JAMA Oncology|April 17, 2025
Adoption of Broad Genomic Profiling in Patients With CancerXiao Wang, John Rothen, Sida Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy EraXiao Wang, Jessica B Long, John Rothen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
A Taxonomy for Assessing Real-World Targeted Cancer Therapy Options in the Context of Broad Genomic ProfilingXiao Wang, Jessica B Long, John Rothen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Archives of Public Health = Archives Belges De Sante Publique|May 29, 2023
Improving value for underserved populations with a community-based intervention: a retrospective cohort studyClaude Pinnock, John Rothen, Tom Carlough, et al.
JAMA Oncology|May 7, 2026
Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate CancerMichael S Leapman, John Rothen, Jessica B Long, et al.
JAMA Network Open|May 27, 2026
Medicare Insurance Type and Broad Genomic Profiling in Metastatic CancerRyan D Chow, John Rothen, Jessica B Long, et al.
JAMA Oncology|April 17, 2025
Adoption of Broad Genomic Profiling in Patients With CancerXiao Wang, John Rothen, Sida Huang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
BPI25-017: A Novel Integrated Classification Schema for Molecular Findings by Potential Clinical Actionability: A Tool for Assessment of Real-World Cancer Care in the Targeted Therapy EraXiao Wang, Jessica B Long, John Rothen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2026
A Taxonomy for Assessing Real-World Targeted Cancer Therapy Options in the Context of Broad Genomic ProfilingXiao Wang, Jessica B Long, John Rothen, et al.
Pageof 1